CA2154265C - Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound - Google Patents

Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound Download PDF

Info

Publication number
CA2154265C
CA2154265C CA2154265A CA2154265A CA2154265C CA 2154265 C CA2154265 C CA 2154265C CA 2154265 A CA2154265 A CA 2154265A CA 2154265 A CA2154265 A CA 2154265A CA 2154265 C CA2154265 C CA 2154265C
Authority
CA
Canada
Prior art keywords
stress
promoter
gene
responds
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA2154265A
Other languages
English (en)
French (fr)
Other versions
CA2154265A1 (en
Inventor
Spencer B. Farr
Marque D. Todd
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenometrix Inc
Harvard University
Original Assignee
Xenometrix Inc
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21734317&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2154265(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Xenometrix Inc, Harvard University filed Critical Xenometrix Inc
Publication of CA2154265A1 publication Critical patent/CA2154265A1/en
Application granted granted Critical
Publication of CA2154265C publication Critical patent/CA2154265C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
CA2154265A 1993-01-21 1994-01-21 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound Expired - Lifetime CA2154265C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US889693A 1993-01-21 1993-01-21
US08/008,896 1993-01-21
PCT/US1994/000583 WO1994017208A1 (en) 1993-01-21 1994-01-21 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Publications (2)

Publication Number Publication Date
CA2154265A1 CA2154265A1 (en) 1994-08-04
CA2154265C true CA2154265C (en) 2011-01-04

Family

ID=21734317

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2154265A Expired - Lifetime CA2154265C (en) 1993-01-21 1994-01-21 Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound

Country Status (11)

Country Link
US (3) US5811231A (de)
EP (1) EP0680517B2 (de)
JP (1) JP3509100B2 (de)
AT (1) ATE160178T1 (de)
AU (1) AU692434B2 (de)
CA (1) CA2154265C (de)
DE (1) DE69406772T3 (de)
DK (1) DK0680517T4 (de)
ES (1) ES2111289T5 (de)
GR (1) GR3026129T3 (de)
WO (1) WO1994017208A1 (de)

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0680517B2 (de) * 1993-01-21 2005-01-19 President And Fellows Of Harvard College Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung
AU694745B2 (en) * 1993-09-10 1998-07-30 Trustees Of Columbia University In The City Of New York, The Uses of green fluorescent protein
GB9420735D0 (en) * 1994-10-14 1994-11-30 Karobio Ab Reporter cell line
GB9424497D0 (en) * 1994-12-05 1995-01-25 Karobio Ab Reporter cell line
US6387651B1 (en) 1995-04-12 2002-05-14 Biolog, Inc. Comparative phenotype analysis of two or more microorganisms using a plurality of substrates within a microwell device
US6326140B1 (en) 1995-08-09 2001-12-04 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5777888A (en) * 1995-08-09 1998-07-07 Regents Of The University Of California Systems for generating and analyzing stimulus-response output signal matrices
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
GB9526509D0 (en) * 1995-12-23 1996-02-28 Univ Dundee Gene control
US6110671A (en) * 1996-04-04 2000-08-29 The United States Of America As Represented By The Secretary Of The Army Method of measuring tumor suppressor gene p53
US5928888A (en) * 1996-09-26 1999-07-27 Aurora Biosciences Corporation Methods and compositions for sensitive and rapid, functional identification of genomic polynucleotides and secondary screening capabilities
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
CA2279576A1 (en) * 1997-02-28 1998-09-03 E.I. Du Pont De Nemours And Company A method for identifying the site of action of xenobiotic chemicals
GB9706414D0 (en) 1997-03-27 1997-05-14 Univ Manchester Detection of DNA damage
US7031843B1 (en) * 1997-09-23 2006-04-18 Gene Logic Inc. Computer methods and systems for displaying information relating to gene expression data
WO1999016903A1 (en) * 1997-09-29 1999-04-08 Hsp Research Institute, Inc. Method for screening heat shock protein expression induction regulators
CA2310621A1 (en) * 1997-11-20 1999-06-03 Smithkline Beecham Corporation Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
WO1999045152A1 (en) * 1998-03-06 1999-09-10 E.I. Du Pont De Nemours And Company Methods for identifying polycationic, peptide-like compounds with antibacterial activity
US5965352A (en) 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action
WO1999058720A1 (en) * 1998-05-12 1999-11-18 Acacia Biosciences, Inc. Quantitative methods, systems and apparatuses for gene expression analysis
US6132969A (en) * 1998-06-19 2000-10-17 Rosetta Inpharmatics, Inc. Methods for testing biological network models
US6501003B1 (en) * 1998-07-08 2002-12-31 Wisconsin Alumni Research Foundation Transgentic mouse expressing green fluorescent protein in glial cells
US20030105044A1 (en) * 2001-10-17 2003-06-05 Isis Pharmaceuticals Inc. Antisense modulation of matrix metalloproteinase 1 expression
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
US6950752B1 (en) 1998-10-27 2005-09-27 Rosetta Inpharmatics Llc Methods for removing artifact from biological profiles
US6203987B1 (en) 1998-10-27 2001-03-20 Rosetta Inpharmatics, Inc. Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
US6468476B1 (en) * 1998-10-27 2002-10-22 Rosetta Inpharmatics, Inc. Methods for using-co-regulated genesets to enhance detection and classification of gene expression patterns
US6453241B1 (en) * 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
US6801859B1 (en) 1998-12-23 2004-10-05 Rosetta Inpharmatics Llc Methods of characterizing drug activities using consensus profiles
US6222093B1 (en) * 1998-12-28 2001-04-24 Rosetta Inpharmatics, Inc. Methods for determining therapeutic index from gene expression profiles
US6370478B1 (en) 1998-12-28 2002-04-09 Rosetta Inpharmatics, Inc. Methods for drug interaction prediction using biological response profiles
AU4186600A (en) * 1999-03-31 2000-10-16 Rosetta Inpharmatics, Inc. Essential genes of yeast as targets for antifungal agents, herbicides, insecticides and anti-proliferation drugs
EP1045035B1 (de) 1999-04-14 2006-09-20 Sumitomo Chemical Company, Limited Zelle zur Bestimmung der Fähigkeit die Aktivität eines Liganden-abhängigen Transkriptionskontrollfaktors zu kontrollieren
CA2370749A1 (en) 1999-04-20 2000-10-26 Target Discovery, Inc. Polypeptide fingerprinting methods, metabolic profiling, and bioinformatics database
US6673554B1 (en) * 1999-06-14 2004-01-06 Trellie Bioinformatics, Inc. Protein localization assays for toxicity and antidotes thereto
US7049132B1 (en) 1999-06-28 2006-05-23 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
US20060115826A1 (en) * 1999-06-28 2006-06-01 Michael Bevilacqua Gene expression profiling for identification monitoring and treatment of multiple sclerosis
US20080183395A1 (en) * 1999-06-28 2008-07-31 Michael Bevilacqua Gene expression profiling for identification, monitoring and treatment of multiple sclerosis
US20040225449A1 (en) * 1999-06-28 2004-11-11 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using selected gene expression profiles
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US20050060101A1 (en) * 1999-06-28 2005-03-17 Bevilacqua Michael P. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
CA2377434A1 (en) * 1999-06-28 2001-01-04 University Of Southern California Stress-responsive induction of a therapeutic agent and methods of use
US6931396B1 (en) 1999-06-29 2005-08-16 Gene Logic Inc. Biological data processing
US20020087511A1 (en) * 1999-09-02 2002-07-04 Johnson Peter C. Methods for profiling and manufacturing tissue using a database that includes indices representative of a tissue population
US6727100B1 (en) * 1999-10-21 2004-04-27 4Sc Ag Method of identifying candidate molecules
GB2355791B (en) * 1999-10-28 2004-10-20 Molecular Light Tech Res Ltd Detection of mRNA expression using chemiluminescent labelled probes
EP1130086A1 (de) * 2000-02-18 2001-09-05 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Genetische manipulierte Keratinozyten und deren Verwendung zur Prüfung der Toxizität
US20040115627A1 (en) * 2000-04-12 2004-06-17 Judy Raucy Compositions and methods for induction of proteins involved in xenobiotic metabolism
US6696239B1 (en) 2000-04-20 2004-02-24 Biolog, Inc. Comparative phenotype analysis for assessment of biological active compounds such as antimicrobials
US6828097B1 (en) * 2000-05-16 2004-12-07 The Childrens Mercy Hospital Single copy genomic hybridization probes and method of generating same
JP2004523201A (ja) * 2000-05-16 2004-08-05 ザ チルドレンズ マーシー ホスピタル シングルコピーゲノムのハイブリダイゼーションプローブおよびその作製方法
US6902882B2 (en) 2000-05-23 2005-06-07 Kerong Gu Methods of monitoring production of gene products and uses thereof
US20030171876A1 (en) * 2002-03-05 2003-09-11 Victor Markowitz System and method for managing gene expression data
US20030009295A1 (en) * 2001-03-14 2003-01-09 Victor Markowitz System and method for retrieving and using gene expression data from multiple sources
US7020561B1 (en) 2000-05-23 2006-03-28 Gene Logic, Inc. Methods and systems for efficient comparison, identification, processing, and importing of gene expression data
JP2004503256A (ja) * 2000-06-14 2004-02-05 ビスタジェン　インコーポレイテッド 肝臓幹細胞を使用する毒性分類
US20020137053A1 (en) * 2000-07-19 2002-09-26 Dana Ault-Riche Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
EP1409718A2 (de) * 2000-07-21 2004-04-21 Phase-1 Molecular Toxicology Hundegene im zusammenhang mit toxizität
US7613571B2 (en) * 2000-07-28 2009-11-03 Doyle Michael D Method and system for the multidimensional morphological reconstruction of genome expression activity
EP1364049A2 (de) * 2000-07-31 2003-11-26 Gene Logic, Inc. Molekulare modulation von toxizitäten
US7590493B2 (en) * 2000-07-31 2009-09-15 Ocimum Biosolutions, Inc. Methods for determining hepatotoxins
CA2327581A1 (en) * 2000-12-27 2002-06-27 Yves Blais Methods and compositions for the establishment of genetically altered cell-based library designed for monitoring transcriptional activity of compounds and molecules
WO2002059560A2 (en) * 2001-01-23 2002-08-01 Gene Logic, Inc. A method and system for predicting the biological activity, including toxicology and toxicity, of substances
AU2002230372B2 (en) * 2001-02-05 2008-03-13 Shen Quan Pan Methods and kits for identifying scavengers of reactive oxygen species (ROS)
JP2004524843A (ja) * 2001-02-23 2004-08-19 イーラン ファーマスーティカルズ、インコーポレイテッド Ｂａｃｅ−１のトランスジェニックノックアウト
WO2002079391A2 (en) * 2001-04-02 2002-10-10 Cytoprint, Inc. Methods and apparatus for discovering, identifying and comparing biological activity mechanisms
US7415358B2 (en) * 2001-05-22 2008-08-19 Ocimum Biosolutions, Inc. Molecular toxicology modeling
US20070015146A1 (en) * 2001-05-22 2007-01-18 Gene Logic, Inc. Molecular nephrotoxicology modeling
US7447594B2 (en) * 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
WO2003068908A2 (en) * 2001-07-10 2003-08-21 Gene Logic, Inc. Cardiotoxin molecular toxicology modeling
US20070054269A1 (en) * 2001-07-10 2007-03-08 Mendrick Donna L Molecular cardiotoxicology modeling
US20030143612A1 (en) * 2001-07-18 2003-07-31 Pointilliste, Inc. Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening
US7251642B1 (en) 2001-08-06 2007-07-31 Gene Logic Inc. Analysis engine and work space manager for use with gene expression data
EP1427850A4 (de) * 2001-08-16 2006-02-08 Phase 1 Molecular Toxicology I Toxikologisch relevante menschliche gene und arrays
WO2003018839A1 (en) * 2001-08-23 2003-03-06 University College Dublin, National University Of Ireland, Dublin Identification of a common promoter module in disease associated genes
JP2003079365A (ja) 2001-09-07 2003-03-18 Kanegafuchi Chem Ind Co Ltd 環境有害化学物質の高感度検出法
US7842498B2 (en) 2001-11-08 2010-11-30 Bio-Rad Laboratories, Inc. Hydrophobic surface chip
US6964850B2 (en) * 2001-11-09 2005-11-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
WO2003062402A2 (en) * 2002-01-24 2003-07-31 Pointilliste, Inc. Use of collections of binding sites for sample profiling and other applications
JP2005535285A (ja) * 2002-01-31 2005-11-24 ジーン ロジック インコーポレイテッド 分子肝毒性モデリング
ATE426020T1 (de) 2002-01-31 2009-04-15 Univ Rochester Lichtaktivierte gentransduktion unter verwendung von ultraviolettem licht zur zellengerichteten zufuhrung von genen
US7704272B2 (en) 2002-01-31 2010-04-27 University Of Rochester Method for introducing an ultraviolet light activated viral vector into the spinal column
US7469185B2 (en) 2002-02-04 2008-12-23 Ocimum Biosolutions, Inc. Primary rat hepatocyte toxicity modeling
MXPA04011424A (es) * 2002-05-17 2005-02-17 Baylor College Medicine Patrones diferenciales de expresion genetica que predicen la quimioresistencia y quimiosensibilidad a docetaxel.
ITTO20020729A1 (it) * 2002-08-14 2004-02-15 Consorzio Interuniversitario Per Le Biotecnologie Cellule di mammifero non umano geneticamente modificate, procedimento per la loro produzione e utilizzo in test di tossicita'.
WO2004042019A2 (en) * 2002-10-30 2004-05-21 Pointilliste, Inc. Systems for capture and analysis of biological particles and methods using the systems
US20040241748A1 (en) * 2003-02-10 2004-12-02 Dana Ault-Riche Self-assembling arrays and uses thereof
US7853406B2 (en) 2003-06-13 2010-12-14 Entelos, Inc. Predictive toxicology for biological systems
US7727752B2 (en) 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7619059B2 (en) 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
CA2445420A1 (en) 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US20070055448A1 (en) * 2003-08-07 2007-03-08 Gene Logic Inc. Primary rat hepatocyte toxicity modeling
WO2005045426A2 (en) * 2003-11-10 2005-05-19 Aic Gene expression profiling of hazardous compounds and corresponding database clustering algorithm
US20080281526A1 (en) * 2004-03-22 2008-11-13 Diggans James C Methods For Molecular Toxicology Modeling
JP2007533005A (ja) * 2004-04-07 2007-11-15 ジーン ロジック インコーポレイテッド 肝毒性分子モデル
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
US7232808B2 (en) * 2004-08-02 2007-06-19 University Of Iowa Research Foundation Methods of inhibiting manganese-containing superoxide dismutase 2 (MnSOD)
US7646450B2 (en) * 2005-12-29 2010-01-12 Lg Display Co., Ltd. Light emitting diode array, method of manufacturing the same, backlight assembly having the same, and LCD having the same
WO2007092938A2 (en) * 2006-02-08 2007-08-16 Invitrogen Corporation Cellular assays for signaling receptors
EP2069794A1 (de) * 2006-10-03 2009-06-17 University of Southern California Grp78 als mittel zur vorhersage der ansprechbarkeit auf therapeutika
NZ584848A (en) * 2007-09-28 2012-09-28 Intrexon Corp Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof
BRPI0920679A2 (pt) 2008-10-08 2022-05-17 Intrexon Corp Células construídas expressando múltiplos imunomoduladores e usos das mesmas
EP2199794A1 (de) 2008-12-17 2010-06-23 Universiteit Maastricht Verfahren zur Identifizierung von krebserregenden Verbindungen
JP5954883B2 (ja) * 2011-04-08 2016-07-20 アンセム・バイオサイエンシズ・プライベート・リミテッド 真核生物細胞での遺伝毒性物質のハイスループットスクリーニングのためのｉｎｖｉｔｒｏ方法
EP2748338B1 (de) * 2011-09-08 2017-04-26 Attagene, Inc. Systeme und verfahren für ein assay aus biokontaminantien in wasser
US12467050B2 (en) * 2017-10-02 2025-11-11 Georgia Tech Research Corporation Methods and compositions for engineering synthetic bioswitches for remote control of biological activity
JP7072072B2 (ja) 2018-02-09 2022-05-19 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド インプラント可能なアクセスチャンバ及び関連する使用方法
EP4069731A4 (de) 2019-12-03 2024-05-29 Alamar Biosciences, Inc. Nukleinsäure-gekoppelter immun-sandwich-assay (nulisa)
KR102382748B1 (ko) * 2020-07-28 2022-04-05 가톨릭대학교 산학협력단 Egr1 프로모터 영역을 포함하는 재조합 벡터 및 이의 용도

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2533584B1 (fr) * 1982-09-28 1986-03-21 Pasteur Institut Procede de detection du pouvoir mutagene de substances, susceptibles d'induire la deterioration d'adn cellulaires, mettant en jeu la production d'une reponse sos
US4981784A (en) * 1987-12-02 1991-01-01 The Salk Institute For Biological Studies Retinoic acid receptor method
US4997757A (en) * 1987-12-23 1991-03-05 Genebiomed, Inc. Process for detecting potential carcinogens
NL8801826A (nl) * 1988-07-19 1990-02-16 Tno Werkwijze voor het detecteren van mutaties in markergenen.
US5232833A (en) * 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
GB8905394D0 (en) * 1989-03-09 1989-04-19 Delta Biotechnology Ltd Detection of certain molecules
US5149634A (en) * 1989-04-14 1992-09-22 The University Of Maryland Bioassay for environmental quality
ATE238431T1 (de) * 1989-07-18 2003-05-15 Osi Pharm Inc Methode der veränderung der expression von genen bei der transkription und zum nachweis von chemischen substanzen, die wie modulatoren der genexpression wirken
US5665543A (en) * 1989-07-18 1997-09-09 Oncogene Science, Inc. Method of discovering chemicals capable of functioning as gene expression modulators
CA2063826A1 (en) † 1989-07-18 1991-01-19 Christian Pieler Automated laboratory apparatus
US5401629A (en) * 1990-08-07 1995-03-28 The Salk Institute Biotechnology/Industrial Associates, Inc. Assay methods and compositions useful for measuring the transduction of an intracellular signal
JPH06503713A (ja) * 1990-09-24 1994-04-28 ブレント，ロジャー スクリーニング・アッセイ
ATE190354T1 (de) * 1990-12-20 2000-03-15 Arch Dev Corp The University O Kontrolle der genexpression durch ionisierende strahlung
NL9100567A (nl) * 1991-04-02 1992-11-02 Ingeny Bv Werkwijze voor het detecteren van mutaties, transgeen zoogdier, transgene zoogdiercel, en werkwijze voor het onderzoeken van stoffen of omstandigheden op mutagene eigenschappen.
CA2070058A1 (en) * 1991-05-31 1992-12-01 Robert A. Gadski Vectors and methods for assaying the regulation of apolipoprotein ai synthesis
DK0651825T3 (da) * 1992-07-06 1998-09-14 Harvard College Fremgangsmåder og diagnostiske sæt til bestemmelse af en forbindelses toksicitet under anvendelse af en bakterielle stressp
EP0680517B2 (de) * 1993-01-21 2005-01-19 President And Fellows Of Harvard College Verfahren und diagnostische kits unter verwendung von säuger-stresspromotoren zur bestimmung der toxizität einer verbindung

Also Published As

Publication number Publication date
EP0680517A1 (de) 1995-11-08
HK1004920A1 (en) 1998-12-11
JP3509100B2 (ja) 2004-03-22
ES2111289T5 (es) 2005-07-16
JPH09503121A (ja) 1997-03-31
US20030219714A1 (en) 2003-11-27
ES2111289T3 (es) 1998-03-01
DE69406772T2 (de) 1998-03-12
AU692434B2 (en) 1998-06-11
DE69406772T3 (de) 2005-11-17
CA2154265A1 (en) 1994-08-04
US5811231A (en) 1998-09-22
EP0680517B1 (de) 1997-11-12
DE69406772D1 (de) 1997-12-18
US20030027127A1 (en) 2003-02-06
DK0680517T3 (da) 1998-07-27
EP0680517B2 (de) 2005-01-19
DK0680517T4 (da) 2005-05-02
GR3026129T3 (en) 1998-05-29
AU6124394A (en) 1994-08-15
WO1994017208A1 (en) 1994-08-04
ATE160178T1 (de) 1997-11-15

Similar Documents

Publication Publication Date Title
CA2154265C (en) Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
Lester et al. Derepression of genes on the human inactive X chromosome: evidence for differences in locus-specific rates of derepression and rates of transfer of active and inactive genes after DNA-mediated transformation
Galter et al. Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain
AU687353B2 (en) Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes
Lewtas Evaluation of the mutagenicity and carcinogenicity of motor vehicle emissions in short-term bioassays
Bihari et al. DNA damage determination by the alkaline elution technique in the haemolymph of mussel Mytilus galloprovincialis treated with benzo [a] pyrene and 4-nitroquinoline-N-oxide
Mckenna et al. Metallothionein gene expression in testicular interstitial cells and liver of rats treated with cadmium
Williams-Hill et al. Mutagenicity studies of methyl-tert-butylether using the Ames tester strain TA102
Maga et al. Response of S. cerevisiae to N-methyl-N′-nitro-N-nitrosoguanidine: mutagenesis, survival and DDR gene expression
Petersen et al. Gene-specific and strand-specific DNA repair in the G1 and G2 phases of the cell cycle
EP0113769B1 (de) Mutationsassays unter einbeziehung von toxische substanzen umsetzenden blutzellen
Karam et al. Induction of replicative DNA synthesis and PPAR alpha-dependent gene transcription by Wy-14 643 in primary rat hepatocyte and non-parenchymal cell co-cultures.
HK1004920B (en) Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound
Sniegowski A test of the directed mutation hypothesis in Escherichia coli MCS2 using replica plating
Waldren et al. Mutant yields and mutational spectra of the heterocyclic amines MeIQ and PhIP at the S1 locus of human-hamster AL cells with activation by chick embryo liver (CELC) co-cultures
Maher et al. Repair of DNA Damage Induced in Human Fibroblasts by N-Substituted Aryl Compounds 1.2
EP1224328B1 (de) Genetische biosensoren welche chemilumineszenz verwenden
US20060051787A1 (en) Quantitative PCR for analysis of DNA damage induced by PGHS-2 (COX-2) or other factors
Parry The use of short term tests to detect the carcinogenic and mutagenic potential of environmental chemicals
Tirmenstein Comparative metabolism of bis (2-methoxyethyl) ether by rat and human hepatic microsomes: formation of 2-methoxyethanol
Efuet Molecular and genetic investigations on the Azotobacter vinelandii genome
GELS New Methods
Rattray Development of a bioluminescence-based detection system for a genetically modified microorganism
Yao RNA fingerprinting of total bacterial RNA obtained by in situ extraction of soil microcosms inoculated with strain Pseudomonas putida F1
Gagné et al. 4 Fluorescence in situ Hybridization en Suspension (FISHES) Using Biotin-labeled DNA Probes for Measuring Genetic Expression of Metallothionein and Cytochrome P-450 1A1 (CYP1A1) in Rainbow Trout Hepatocytes Exposed to

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140121